Brief: Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits Of Atuzaginstat

IRulya Therapeutics

09/03/2022 13:13

March 9 (Reuters) - Cortexyme Inc  CRTX.O :
    * CORTEXYME ANNOUNCES PRECLINICAL DATA HIGHLIGHTING POTENTIAL THERAPEUTIC
BENEFITS
OF ATUZAGINSTAT FOR TREATMENT OF HIGH-RISK ORAL POTENTIALLY MALIGNANT DISORDERS

Source text for Eikon:  ID:nBw3nbZ7sa 
Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))